Edison, NJ, United States of America

Mary Struthers

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Mary Struthers: Innovator in Immunology

Introduction

Mary Struthers is a prominent inventor based in Edison, NJ (US), known for her significant contributions to the field of immunology. With a total of 12 patents to her name, she has made remarkable strides in developing treatments for immune responses and inflammatory diseases.

Latest Patents

Among her latest patents are innovative methods for the treatment or prevention of immune responses and inflammatory diseases using antagonistic CD40 monoclonal antibodies. These patents disclose antibodies that bind to CD40, including humanized antibodies that do not exhibit CD40 agonist activity. The antibodies may feature a modified IgG1 Fc domain and show minimal activation of immature dendritic cells. Additionally, the patents provide compositions comprising these antibodies, methods for treating diseases involving CD40 activity, and their use in preparing medicaments for such treatments.

Career Highlights

Mary Struthers is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work has been instrumental in paving the way for new therapeutic approaches in immunology.

Collaborations

Throughout her career, Mary has collaborated with notable colleagues, including Stanley Richard Krystek, Jr. and Akbar Nayeem, contributing to a dynamic research environment that fosters innovation.

Conclusion

Mary Struthers exemplifies the spirit of innovation in the field of immunology, with her groundbreaking patents and collaborative efforts. Her work continues to impact the development of treatments for complex immune-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…